Increase in investments and funding for R&D interventions & rise in production of biopharmaceuticals, and untapped potential in developing countries

PORTLAND, OR, UNITED STATES, October 12, 2021 /EINPresswire.com/ -- Increase in production of biopharmaceuticals and rise in investments and funding for R&D interventions in both developed and emerging countries have boosted the growth of the global biotechnology media, sera and reagents market. However, dearth of skilled personnel and ethical & scientific concerns associated with the misuse of biotechnology research practices hamper the market growth. On the contrary, untapped markets in the developing countries and rise in preference for specialty media are expected to create lucrative opportunities in the coming years.

"Biotechnology Media, Sera and Reagents Market by Type (Media, Sera and Reagent), Application (Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, and Others), and End User (Biotechnology & Pharmaceutical Companies, Academic Institute, Research Laboratory): Global Opportunity Analysis and Industry Forecast, 2018 – 2025". According to the report, the global biotechnology media, sera, and reagents market accounted for $18.79 billion in 2017 and is projected to reach $32.98 billion by 2025, registering a CAGR of 7.3% during the period from 2018 to 2025.

Explore Report Description@ https://www.alliedmarketresearch.com/biotechnology-media-sera-and-reagents-market

Media segment to manifest fastest growth by 2025

The media segment is expected to manifest the fastest CAGR of 8.1% during the forecast period. However, the reagents segment held the largest market share in 2017, contributing nearly three-fourths of the total market share. The report also includes analysis of the sera segment.

Cancer research dominates the market

The cancer research segment held the largest share in 2017, contributing nearly one-third of the total market. However, the biopharmaceuticals segment is projected to manifest the fastest CAGR of 8.2% through 2025. The report analyzes other segments such as regenerative medicine and tissue engineering among others.

Biotechnology and pharmaceutical companies: Most lucrative segment

The biotechnology and pharmaceutical companies segment held the largest share in 2017, contributing nearly half of the total market. Moreover, the segment is projected to register the fastest growth with a CAGR of 8% during the study period. The report includes other segments such as research laboratories and academic institutes.

Asia-Pacific segment to portray fastest growth through 2025

The Asia-Pacific region is estimated to portray the fastest CAGR of 8.9% through 2025, owing to increased penetration of leading biotech companies such as Thermo Fischer, Bio-Rad and others in the region. However, the North America region held the largest share in 2017, contributing about 46% of the total market, owing to well-established biotechnology research companies as well as research laboratories in the region. The report includes analysis of the other regions such as Europe and Latin America, Middle East and Africa (LAMEA).

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5176

Major market players:-

The report provides a comprehensive analysis of the leading companies operating in the global market such as GE Healthcare, Bio-Rad laboratories Inc., Merck KGaA (Sigma Aldrich), Sartorius AG, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, Merck & Co., Inc., Thermofisher Scientific, Corning Incorporated, Becton, Dickinson and Company. The other players in the value chain (not included in the report) include Takara Bio, Inc., Cyagen Biosciences, PeproTech, Inc., Avantor Performance Materials, LLC (VWR International, LLC), Caisson Laboratories, Inc., Cell Culture Technologies LLC and Biomol GmbH.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry:

Cervical Dysplasia Market Global Research By 2030

Clear Aligners Market Global Research By 2030

Consumer Genomics Market Global Research By 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn